Comparison

Dopamine beta-Hydroxylase Protein, Human, Recombinant (His) European Partner

Item no. TMO-TMPY-03852-50ug
Manufacturer TargetMol
Amount 50 ug
Quantity options 10 ug 20 ug 50 ug 50 ug 5 ug
Category
Type Inhibitors
Specific against other
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias dopamine β-hydroxylase (dopamine β-monooxygenase),dopamine beta-hydroxylase (dopamine beta-monooxygenase),Dopamine β-Hydroxylase,DBM
Shipping Condition Cool pack
Available
Shipping Temperature
Cool pack
Storage Conditions
-20°C
Molecular Weight
67.3 kDa (predicted); 68 kDa (reducing condition, due to glycosylation)
Description
DBH is a 29 kDa copper-containing oxygenase. It can be detected in noradrenergic nerve terminals of the central and peripheral nervous systems, and is also expressed in chromaffin cells of the adrenal medulla. DBH contains our identical subunits, and its activity requires ascorbate as a cofactor. It functions in in the synthesis of small-molecule neurotransmitters that is membrane-bound, making norepinephrine the only transmitter synthesized inside vesicles. DBH has been shown to be associated with decision making and addictive behaviors such as alcohol and smoking, attention deficit hyperactivity disorder, and also with neurological diseases such as Schizophrenia and Alzheimer's.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close